Indeed, in different models, GSDME activation promotes tumor suppression by increasing the anticancer properties of tumor-infiltrating natural killer (NK) cells and CD4+ and CD8+ T lymphocytes, together with an antitumor vaccination effect, triggering both innate and adaptive antitumor immunity [170,171,259]. The gene discussed is CD4; the disease is neoplasm.